RAP - The Next Phase, page-1279

Because it opens up the next phase. The trials need to happen in a US hospital to achieve FDA approval.

In the USA they already have established telehealth channels - numerous channels even.

The US is the key in this whole puzzle. Once this gets cranking the real action starts, we have only seem the entree so far, if that even.

As was mentioned by another posted recently, the importance of the HCF GP2U service cannot be underestimated. It shows the first real shift in telehealth from a major health provider in this country.

Once things get rolling in the USA, I am sure the share price will reflect that.

Cheers,

Bern